☆ 4.4 Letter

JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)

期刊

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

卷 94, 期 3, 页码 435-437

出版社

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.13587

关键词

类别

Hematology

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.4

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines

Omar Perbellini, Chiara Cavallini, Roberto Chignola, Marilisa Galasso, Maria T. Scupoli

Summary: This study reveals a high variability in signaling networks across different T-ALL cell lines and provides insight into the characterization of these differences using phospho-specific flow cytometry.

CELLS (2022)

添加到收藏夹

Article Medicine, Research & Experimental

In Vitro Inhibitory Effect of Succinic Acid on T-Cell Acute Lymphoblastic Leukemia Cell Lines

Baris Ertugrul, Elif Sinem Iplik, Bedia Cakmakoglu

Summary: The study found that succinic acid has apoptotic effects on T-ALL cell lines without significant cytotoxic effects on healthy cells. The apoptotic activity of succinic acid on CCRF-CEM cell line is caspase-3 dependent, while it is not for MOLT-4 cell line.

ARCHIVES OF MEDICAL RESEARCH (2021)

添加到收藏夹

Editorial Material Immunology

Acute Lymphoblastic Leukemia Cell Lines in Immunology Research

Salvador Valle-Reyes, Oxana Dobrovinskaya, Rosana Pelayo, Michael Schnoor

Summary: A significant amount of knowledge on T and B cell biology is obtained from research using ALL cell lines, which are crucial tools in immunology and leukemia studies. Understanding the advantages and limitations of ALL cell lines is important for their proper utilization.

TRENDS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

Robert Chiesa, Christos Georgiadis, Farhatullah Syed, Hong Zhan, Annie Etuk, Soragia Athina Gkazi, Roland Preece, Giorgio Ottaviano, Toni Braybrook, Jan Chu, Agnieszka Kubat, Stuart Adams, Rebecca Thomas, Kimberly Gilmour, David O'Connor, Ajay Vora, Waseem Qasim

Summary: Base editing technique has been used to inactivate genes and treat relapsed childhood T-cell leukemia with promising results.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Oncology

The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia

Emanuele Murgo, Elisabetta De Santis, Francesca Sansico, Valentina Melocchi, Tommaso Colangelo, Costanzo Padovano, Mattia Colucci, Annalucia Carbone, Beatrice Totti, Alireza Basti, Lisa Gottschlich, Angela Relogio, Nazzareno Capitanio, Fabrizio Bianchi, Gianluigi Mazzoccoli, Vincenzo Giambra

Summary: This study investigates the role of the biological clock in the regulation of cellular dynamics in T-ALL. The disruption of the circadian clock negatively affects LIC activity and JAK/STAT signaling in T-ALL cells. Targeting circadian components could be a potential therapeutic strategy for T-ALL treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

添加到收藏夹

Article Cell Biology

Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia

Mayumi Sugita, Takahiro Yamazaki, Mohammad Alhomoud, Jeremie Martinet, Jean-Baptiste Latouche, Encouse Golden, Olivier Boyer, Koen Van Besien, Silvia C. Formenti, Lorenzo Galluzzi, Monica L. Guzman

Summary: Autologous T cells engineered with CAR specific for CD19 have been approved for treating CD19(+) hematological malignancies. However, relapse often occurs when neoplastic cells lose CD19 expression. Preclinical models have shown that radiation therapy (RT) can overcome CD19 loss by inducing death receptor expression in cancer cells. Using a human model of CD19(+) acute lymphoblastic leukemia (ALL), it was found that low-dose total body irradiation (LD-TBI) administered before CAR T cell infusion significantly improved overall survival and CAR T cell expansion. These findings support the initiation of clinical trials combining LD-TBI with CAR T cells.

CELL DEATH & DISEASE (2023)

添加到收藏夹

Review Hematology

Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights

Ilaria Iacobucci, Matthew T. Witkowski, Charles G. Mullighan

Summary: Despite advances in identifying genetic drivers of ALL, prognosis for disease recurrence remains poor. Single-cell sequencing approaches are being used to explore various aspects of ALL biology, such as cell of origin, molecular heterogeneity, and interactions between leukemia cells and the microenvironment. These approaches have provided insights into gene expression, cellular differentiation, and clonal architecture in ALL, but there are still limitations to consider.

BLOOD (2023)

添加到收藏夹

Article Oncology

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia

Giulia Veltri, Federica Lovisa, Giuliana Cortese, Marta Pillon, Elisa Carraro, Simone Cesaro, Massimo Provenzi, Salvatore Buffardi, Samuela Francescato, Alessandra Biffi, Barbara Buldini, Valentino Conter, Valentina Serafin, Lara Mussolin

Summary: T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) share common features but have different phosphoproteomic profiles. A proteomic signature of six proteins can distinguish stage IV T-LBL from T-ALL, and AKT hyperphosphorylation alone can distinguish stage IV T-LBL from both T-ALL and stage III T-LBL.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

T-Cell Acute Lymphoblastic Leukemia-Current Concepts in Molecular Biology and Management

Parveen Shiraz, Waqas Jehangir, Vaibhav Agrawal

Summary: T-cell acute lymphoblastic leukemia (T-ALL) is a rare but aggressive leukemia with CDKN2A/CDKN2B and NOTCH1 being the most common mutated genes. While outcomes for de-novo disease are improving, patients with relapsed and refractory T-ALL have poor prognosis. New targeted therapies show potential to further improve outcomes, and the role of allogeneic stem cell transplant is evolving with the increased use of pediatric-inspired regimens.

BIOMEDICINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

Martina Del Gaizo, Ilaria Sergio, Sara Lazzari, Samantha Cialfi, Maria Pelullo, Isabella Screpanti, Maria Pia Felli

Summary: This article reviews the literature on the regulatory role of miRNAs in the immune response of T-ALL, focusing on their roles in Natural Killer, T, T-regulatory, and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the field of leukemia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Oncology

TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia

Cunte Chen, Lingling Zhou, Lihua Zhu, Gengxin Luo, Liang Wang, Chengwu Zeng, Hongsheng Zhou, Yangqiu Li

Summary: TNFAIP3 mutation mainly occurs in adult T-ALL patients and is associated with adverse clinical outcomes, making it a potential biomarker for prognostic stratification.

CANCER MEDICINE (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia

Huizhong Xiong, Maicol Mancini, Michael Gobert, Shiqian Shen, Glaucia C. Furtado, Sergio A. Lira, Christopher N. Parkhurst, Veronique Garambois, Muriel Brengues, Carlos E. Tadokoro, Thomas Trimarchi, Gonzalo Gomez-Lopez, Amartya Singh, Hossein Khiabanian, Sonia Minuzzo, Stefano Indraccolo, Camille Lobry, Iannis Aifantis, Daniel Herranz, Juan J. Lafaille, Antonio Maraver

Summary: The study revealed that Notch pathway activity in T-ALL depends on DLL4 signaling, while the spleen plays a major role in DLL4-driven T-ALL.

THERANOSTICS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia

Maike Bensberg, Olof Rundquist, Aida Selimovic, Cathrine Lagerwall, Mikael Benson, Mika Gustafsson, Hartmut Vogt, Antonio Lentini, Colm E. Nestor

Summary: TET2 silencing in T-ALL is associated with hypermethylation, and treatment with 5-azacytidine can reduce toxicity in TET2-silenced T-ALL cells, leading to stable re-expression of the TET2 gene.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia

Mina Noura, Hidemasa Matsuo, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa

Summary: TAL1 is frequently dysregulated in T-ALL, and its overexpression is associated with unfavorable clinical outcomes. This study found that the tumor suppressor KLF4 can suppress SE-driven TAL1 expression in T-ALL cells by inhibiting the formation of 5' TAL1 super-enhancer. A small molecule inducer of KLF4, APTO-253, exerts an anti-leukemic effect by targeting SE-driven TAL1 expression in T-ALL cells. Induction of KLF4 may be a promising strategy to control TAL1 expression and could serve as a novel treatment for T-ALL patients with poor prognosis.

ONCOGENE (2023)

添加到收藏夹

Review Oncology

Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia

Francesco Tamiro, Andrew P. Weng, Vincenzo Giambra

Summary: Leukemia-initiating cells (LIC) are unique cells in different types of leukemia that have self-renewing capabilities and produce tumors, which are functionally distinct from bulk leukemia cells. Current conventional treatments are not effective in eliminating LICs, hence innovative therapeutics targeting LICs hold promise for developing an effective cure for ALL.

CANCER RESEARCH (2021)

添加到收藏夹

Article Hematology

Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping

Katrina Rack, Jolien De Bie, Genevieve Ameye, Olga Gielen, Sofie Demeyer, Jan Cools, Kim De Keersmaecker, Joris R. Vermeesch, Johan Maertens, Heidi Segers, Lucienne Michaux, Barbara Dewaele

Summary: Acute lymphoblastic leukemia (ALL) is a malignant disease that can be divided into distinct subtypes based on clinical and genomic features. Traditional diagnostic methods are laborious and costly. This study applied optical genome mapping (OGM) to diagnose ALL and found that OGM can accurately detect common genomic abnormalities, improve the detection rate and cytogenetic resolution, and reduce turnaround time.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells

Benno Verbelen, Tiziana Girardi, Sergey O. Sulima, Stijn Vereecke, Paulien Verstraete, Jelle Verbeeck, Jonathan Royaert, Sonia Cinque, Lorenzo Montanaro, Marianna Penzo, Maya Imbrechts, Nick Geukens, Thomas Geuens, Koen Dierckx, Daniele Pepe, Kim Kampen, Kim De Keersmaecker

Summary: This study presents a novel approach to improve protein yields in mammalian cells by directly engineering the cellular translation machinery. The introduction of RPL10-R98S mutation was found to enhance translation levels and fidelity, reduce proteasomal activity, and increase the production of recombinant proteins. However, the extent of production gain depends on culture conditions, cell type, and the nature of the expressed protein.

ENGINEERING IN LIFE SCIENCES (2022)

添加到收藏夹

Article Hematology

HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia

Marie-Francoise O'donohue, Lydie Da Costa, Marco Lezzerini, Sule Unal, Clement Joret, Marije Bartels, Eva Brilstra, Marijn Scheijde-Vermeulen, Ludivine Wacheul, Kim De Keersmaecker, Stijn Vereecke, Veerle Labarque, Manon Saby, Sophie D. Lefevre, Jessica Platon, Nathalie Montel-Lehry, Nathalie Laugero, Eric Lacazette, Koen van Gassen, Riekelt H. Houtkooper, Pelin Ozlem Simsek-Kiper, Thierry Leblanc, Nese Yarali, Arda Cetinkaya, Nurten A. Akarsu, Pierre-Emmanuel Gleizes, Denis L. J. Lafontaine, Alyson W. MacInnes

Summary: The study reports that individuals with biallelic HEATR3 variants exhibit bone marrow failure, short stature, dysmorphic features, and intellectual disability, similar to Diamond-Blackfan anemia. These variants destabilize a protein important for nuclear import, impacting ribosomal subunit formation and p53 tumor suppressor stabilization.

BLOOD (2022)

添加到收藏夹

Meeting Abstract Hematology

A Noncoding Germline Variant Creates a Gain-of-Function De Novo Enhancer That up-Regulates IL5 Transcription to Cause Familial Hypereosinophilia, Revealing a Previously Undescribed Mechanism for Human Disease

Jung-Hyun Kim, Abbie Bowman, Senbagavalli Babu, Jan Cools, Sofie Demeyer, Majid Kazemian, Warren Leonard, Jian-Xin Lin, Michelle Makiya, Mathieu Perez, Colin L. Sweeney, Luis M. Franco, Neelam Redekar, Justin Lack, Linda Resar, Amy D. Klion

BLOOD (2022)

添加到收藏夹

Article Oncology

A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling

Patricia Altea-Manzano, Ginevra Doglioni, Yawen Liu, Alejandro M. Cuadros, Emma Nolan, Juan Fernandez-Garcia, Qi Wu, Melanie Planque, Kathrin Julia Laue, Florencia Cidre-Aranaz, Xiao-Zheng Liu, Oskar Marin-Bejar, Joke Van Elsen, Ines Vermeire, Dorien Broekaert, Sofie Demeyer, Xander Spotbeen, Jakub Idkowiak, Aurelie Montagne, Margherita Demicco, H. Furkan Alkan, Nick Rabas, Carla Riera-Domingo, Francois Richard, Tatjana Geukens, Maxim De Schepper, Sophia Leduc, Sigrid Hatse, Yentl Lambrechts, Emily Jane Kay, Sergio Lilla, Alisa Alekseenko, Vincent Geldhof, Bram Boeckx, Celia de la Calle Arregui, Giuseppe Floris, Johannes V. Swinnen, Jean-Christophe Marine, Diether Lambrechts, Vicent Pelechano, Massimiliano Mazzone, Sara Zanivan, Jan Cools, Hans Wildiers, Veronique Baud, Thomas G. P. Gruenewald, Uri Ben-David, Christine Desmedt, Ilaria Malanchi, Sarah-Maria Fendt

Summary: The formation of pre-metastatic niche and high-fat diet can increase palmitate availability in future organs of metastases, promoting NF-kappa B acetylation and inducing metastatic signaling. Deletion of acetyltransferase and palmitoyltransferase reduces metastasis formation.

NATURE CANCER (2023)

添加到收藏夹

Article Oncology

Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer

Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Shauni L. Geeraerts, Tom Venken, Kalina Timcheva, David Nittner, Jelle Verbeeck, Jonathan Royaert, Marion Gijbels, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, Kim R. Kampen

Summary: This study identifies the transcription factor NKX2-1 as a driver of serine/glycine synthesis addiction in cancer cells. NKX2-1 binds and transcriptionally upregulates serine/glycine synthesis enzyme genes, enabling cells expressing NKX2-1 to proliferate and invade in serine/glycine-depleted conditions. The findings reveal the unique metabolic rewiring of NKX2-1-driven cancers and provide possibilities for new therapeutic strategies.

BRITISH JOURNAL OF CANCER (2023)

添加到收藏夹

Editorial Material Hematology

Targeting STAT5B in T-cell acute lymphoblastic leukemia

Alexandra Veloso, Jan Cools

Summary: In this article, Tremblay et al demonstrate that activation of STAT5B promotes proliferation, self-renewal, and chemoresistance of leukemia stem cells (LSCs) in an early T-cell precursor acute lymphoblastic leukemia mouse model and explore STAT5B as a direct therapeutic target.

BLOOD (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Drivers of de novo Serine/Glycine synthesis in acute leukemia

Paulien Verstraete, Kim De Keersmaecker, Kim Rosalie Kampen

Summary: Cancer cells increase their production of serine and glycine through metabolic rewiring, specifically through upregulation of de novo serine/glycine synthesis. This review focuses on the upregulation of endogenous serine/glycine production in acute leukemia, including T-cell acute leukemia (T-ALL) and acute myeloid leukemia (AML). Genetic lesions directly impacting serine/glycine addiction in acute leukemia have been identified, along with indirect regulation of de novo serine/glycine synthesis.

FEBS LETTERS (2023)

添加到收藏夹

Article Cell & Tissue Engineering

APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells

Samantha Zaunz, Jonathan De Smedt, Lukas Lauwereins, Lana Cleuren, Charlie Laffeber, Manmohan Bajaj, Joyce H. G. Lebbink, Jurgen A. Marteijn, Kim De Keersmaecker, Catherine Verfaillie

Summary: APEX1 plays a crucial role in adult regenerative hematopoiesis, with its nuclease and redox domains impacting proliferating HSPCs differently.

STEM CELL REVIEWS AND REPORTS (2023)

添加到收藏夹

Meeting Abstract Biochemistry & Molecular Biology

Primary mediastinal large B-cell lymphoma is hallmarked by large-scale copy-neutral loss of heterozygosity

Stefania Tuveri, Koen Debackere, Lukas Marcelis, Nicolas Dierckxsens, Jonas Demeulemeester, Eftychia Dimitriadou, Daan Dierickx, Pierre Lefesvre, Karen Deraedt, Carlos Graux, Lucienne Michaux, Jan Cools, Thomas Tousseyn, Joris Vermeesch, Iwona Wlodarska

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

添加到收藏夹

Meeting Abstract Hematology

ABERRANT MYCN OVEREXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA

Marlies Vanden Bempt, Koen Debackere, Alexandra Veloso, Sofie Demeyer, Thomas Slegers, Quentin Van Thillo, Jan Cools, Daan Dierickx

EXPERIMENTAL HEMATOLOGY (2023)

添加到收藏夹

Meeting Abstract Hematology

UNRAVELLING DRUG RESISTANCE AND SENSITIZATION TO PROTEASOME INHIBITORS USING GENOME-WIDE CRISPR-CAS9 KNOCKOUT SCREENING.

Sophie Vlayen, Marino Caruso, Kim De Keersmaecker, Dirk Daelemans, Michel Delforge

EXPERIMENTAL HEMATOLOGY (2023)

添加到收藏夹

Meeting Abstract Hematology

IDENTIFICATION OF THERAPEUTIC STRATEGIES DIRECTED TO ACUTE MYELOID LEUKEMIA MINIMAL RESIDUAL DISEASE

N. van Gils, F. L. Kessler, M. Broux, F. Denkers, A. Rutten, S. Demeyer, J. Cools, D. C. de Leeuw, J. J. W. M. Janssen, L. Smit

ANNALS OF HEMATOLOGY (2023)

添加到收藏夹

Article Hematology

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing

Sarah Meyers, Llucia Alberti-Servera, Olga Gielen, Margot Erard, Toon Swings, Jolien De Bie, Lucienne Michaux, Barbara Dewaele, Nancy Boeckx, Anne Uyttebroeck, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools, Sofie Demeyer

Summary: This study used single cell-targeted DNA sequencing to evaluate the clonal heterogeneity of B-ALL and found that half of the cases showed multiple subclones at diagnosis. During chemotherapy treatment, leukemia clones disappeared and even rare mutant cells were easily detectable by single cell-targeted DNA sequencing.

HEMASPHERE (2022)

添加到收藏夹

暂无数据

JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines

期刊

出版社

FERRATA STORTI FOUNDATION

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文